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BY-NC-ND license (http://creativecomAbstract This report discusses a new development in the use of ultrasound microbubble
contrast agents on transdermal drug delivery. The medium surrounding the microbubbles at
the optimum concentration from liquid to gel can be modified and it can still achieve the same
enhancement for transdermal drug permeation as liquid medium. It was also found that under
the same ultrasound power density, microbubbles of larger particle sizes can extend the pene-
tration depths of dye at the phantom surface.
ª 2016, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).In current practice, there are three types of transdermal
drug absorption: (1) direct permeation through the lip-
ideprotein matrix of the stratum corneum; (2) permeation
through intercellular lamellar lipid bilayers; and (3)
permeation across the skin barrier in the subsidiary organs
(hair follicles and sweat glands) to reach subcutaneous
tissue [1,2]. Because the stratum corneum is hydrophobic,r declares no conflicts of
ssociate Professor, Graduate
ational Taiwan University of
3, Keelung Rd., Sec. 4, Taipei
du.tw.
.08.009
C and the Chinese Taipei Society o
mons.org/licenses/by-nc-nd/4.0/large molecules or hydrophilic drugs are likely to be
transported through subsidiary organs; however, hair folli-
cles, sweat glands, and sebaceous glands constitute only
0.1% of the total skin area. Therefore, the main route of
drug transport is permeation across the stratum corneum.
Published reports have claimed that damage to the stratum
corneum can increase the amount of drug that is absorbed,
suggesting that the stratum corneum is the main factor that
influences drug permeation. The stratum corneum can
hinder the rate of skin permeation of drugs, allowing only
small molecules (with a molecular weight < 500 Da) to
permeate through [3]. At present, there are numerous
methods to improve transdermal drug transport, including
physical permeation-enhancement technology (iontopho-
resis, electrophoresis, ultrasound, microneedles, andf Ultrasound in Medicine. This is an open access article under the CC
).
Figure 1 Schematic diagram of ultrasound-mediated micro-
bubble contrast agents for enhancement of transdermal
permeation. US Z ultrasound.
Ultrasound in Biomedical Engineering 87laser), chemical permeation-enhancement technology
[various chemical permeation enhancers including cop-
per(II) azide], and pharmaceutical approaches (micro-
emulsions, liposomes, and nanoparticles). Moreover, drugs
can be applied to the skin in the form of creams, ointments,
and patches. In recent years, microneedle array has been
considered a novel minimally invasive approach to enhance
transdermal permeation of large molecule drugs. This
report discusses a new development in the use of ultra-
sound microbubble contrast agents on transdermal drug
delivery.
In clinical applications, microbubbles serve as imaging
agents to enhance the contrast of ultrasound images via
intravenous injection. Different degrees of microbubble
oscillation due to distinct acoustic fields can elicit various
degrees of cavitation. Inertial cavitation can enhance the
permeability in the surrounding tissues, increase vessel
wall permeability, and promote drug entry from blood into
the cytosol or matrix, whereas stable cavitation can
slightly increase tissue permeability without causing any
harm. In November 2015, Canadian researchers, for theFigure 2 The upper row represents the variation in depth of pen
different particle sizes in combination with sonication at the same
acquired after edge detection. UZ ultrasound.first time, utilized focused ultrasound to cause preinjected
microbubble contrast agents in the blood vessels to
vibrate, successfully opening the bloodebrain barrier in
the human brain, thus allowing more effective delivery of
chemotherapy into a brain tumor [4]. This approach is
based on cavitation generated by ultrasound-driven
microbubble oscillation. In 2010, scientists in Korea first
conducted an in-vitro experimental study to investigate
the potential of microbubbles for transdermal drug
permeation, and found that the combination of ultrasound
and microbubbles can indeed effectively promote trans-
dermal permeation. During their research, they discovered
that by evenly applying 0.1% commercial ultrasound
microbubble contrast agent in conjunction with designated
ultrasound energy, cavitation can be generated more uni-
formly in the skin area of interest and thus increase skin
permeability [5].
At present, most ultrasound contrast agents are
designed for injection into blood vessels; nevertheless,
microbubbles with different condition parameters are
highly correlated with efficiency in transdermal perme-
ation. In a study published by our laboratory in 2013, we
found that on the round window membrane of the ear, the
efficiency of drug delivery can be greatly improved by up
to 38 times, with the use of microbubbles at a specific
concentration coupled with ultrasound to increase
permeability of the round window membrane, followed by
application of the drug onto the round window membrane
[6]. As for applications in a transdermal permeation, we
also used microbubbles at a given concentration in com-
bination with ultrasound to widen intercellular spaces
(Figure 1), thereby successfully enhancing the in vivo
delivery of arbutin across the skin. In order for liquid-
phase microbubbles to be conveniently applied to the
skin surface, our team modified the medium surrounding
the microbubbles at the optimum concentration from
liquid to gel. Although gel medium slightly hinders the
efficiency of microbubble oscillation, it can still achieve
the same enhancement for transdermal drug permeation
as liquid medium does with the adjustments toward op-
timum gel ratio and microbubble concentration [7];etration of the dye in phantoms after loading microbubbles of
power density; the lower row shows the corresponding images
88 A.-H. Liaohowever, questions about the regulation of drug pene-
tration depth and the permeation of big molecule drugs
still merit attention.
Subsequently, our research team controlled the micro-
bubble diameter at three distinct particle sizes of 1.4 mm,
2.1 mm, and 3.5 mm by changing the formulation ratios
during the microbubble production process, and conducted
agarose phantom experiment coupled with ultrasound at
different power densities. Figure 2 shows different pene-
tration depths of the dye in tissue phantoms after loading
microbubbles of different sizes followed by a successive
sonication at the power density of 3 W/cm2 for 1 minute. It
was found that under the same ultrasound power density,
microbubbles of larger particle sizes can extend the
penetration depths of dye at the phantom surface. Addi-
tionally, our drug transport model and in vivo results have
demonstrated that the combination of lipophilic vitamin C
derivative (with the molecular weight of 1129.8 Da) and
3.5-mm microbubbles along with ultrasound is the most
effective in enhancing transdermal permeation [8]. Thus,
we conclude that microbubbles play a versatile and sig-
nificant role in the process of ultrasound-driven drug de-
livery, with the versatility to adjust variations in drug
permeation as their greatest advantage over other drug-
enhancement approaches.References
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